Changes in albuminuria predict mortality and morbidity in patients with vascular disease

Roland E. Schmieder, Johannes F E Mann, Helmut Schumacher, Peggy Gao, Giuseppe Mancia, Michael A. Weber, Matthew McQueen, Teo Koon, Salim Yusuf

Research output: Contribution to journalArticle

179 Citations (Scopus)

Abstract

The degree of albuminuria predicts cardiovascular and renal outcomes, but it is not known whether changes in albuminuria also predict similar outcomes. In two multicenter, multinational, prospective observational studies, a central laboratory measured albuminuria in 23,480 patients with vascular disease or high-risk diabetes. We quantified the association between a greater than or equal to twofold change in albuminuria in spot urine from baseline to 2 years and the incidence of cardiovascular and renal outcomes and all-cause mortality during the subsequent 32 months. A greater than or equal to twofold increase in albuminuria from baseline to 2 years, observed in 28%, associated with nearly 50% higher mortality (HR 1.48; 95% CI 1.32 to 1.66), and a greater than or equal to twofold decrease in albuminuria, observed in 21%, associated with 15% lower mortality (HR 0.85; 95% CI 0.74 to 0.98) compared with those with lesser changes in albuminuria, after adjustment for baseline albuminuria, BP, and other potential confounders. Increases in albuminuria also significantly associated with cardiovascular death, composite cardiovascular outcomes (cardiovascular death, myocardial infarction, stroke, and hospitalization for heart failure), and renal outcomes including dialysis or doubling of serum creatinine (adjusted HR 1.40; 95% CI 1.11 to 1.78). In conclusion, in patients with vascular disease, changes in albuminuria predict mortality and cardiovascular and renal outcomes, independent of baseline albuminuria. This suggests that monitoring albuminuria is a useful strategy to help predict cardiovascular risk.

Original languageEnglish
Pages (from-to)1353-1364
Number of pages12
JournalJournal of the American Society of Nephrology
Volume22
Issue number7
DOIs
Publication statusPublished - Jul 2011

Fingerprint

Albuminuria
Vascular Diseases
Morbidity
Mortality
Kidney
Observational Studies
Dialysis
Creatinine
Hospitalization
Heart Failure
Stroke
Myocardial Infarction
Urine

ASJC Scopus subject areas

  • Nephrology

Cite this

Schmieder, R. E., Mann, J. F. E., Schumacher, H., Gao, P., Mancia, G., Weber, M. A., ... Yusuf, S. (2011). Changes in albuminuria predict mortality and morbidity in patients with vascular disease. Journal of the American Society of Nephrology, 22(7), 1353-1364. https://doi.org/10.1681/ASN.2010091001

Changes in albuminuria predict mortality and morbidity in patients with vascular disease. / Schmieder, Roland E.; Mann, Johannes F E; Schumacher, Helmut; Gao, Peggy; Mancia, Giuseppe; Weber, Michael A.; McQueen, Matthew; Koon, Teo; Yusuf, Salim.

In: Journal of the American Society of Nephrology, Vol. 22, No. 7, 07.2011, p. 1353-1364.

Research output: Contribution to journalArticle

Schmieder, RE, Mann, JFE, Schumacher, H, Gao, P, Mancia, G, Weber, MA, McQueen, M, Koon, T & Yusuf, S 2011, 'Changes in albuminuria predict mortality and morbidity in patients with vascular disease', Journal of the American Society of Nephrology, vol. 22, no. 7, pp. 1353-1364. https://doi.org/10.1681/ASN.2010091001
Schmieder, Roland E. ; Mann, Johannes F E ; Schumacher, Helmut ; Gao, Peggy ; Mancia, Giuseppe ; Weber, Michael A. ; McQueen, Matthew ; Koon, Teo ; Yusuf, Salim. / Changes in albuminuria predict mortality and morbidity in patients with vascular disease. In: Journal of the American Society of Nephrology. 2011 ; Vol. 22, No. 7. pp. 1353-1364.
@article{4599473f969146368e94077c87c4873f,
title = "Changes in albuminuria predict mortality and morbidity in patients with vascular disease",
abstract = "The degree of albuminuria predicts cardiovascular and renal outcomes, but it is not known whether changes in albuminuria also predict similar outcomes. In two multicenter, multinational, prospective observational studies, a central laboratory measured albuminuria in 23,480 patients with vascular disease or high-risk diabetes. We quantified the association between a greater than or equal to twofold change in albuminuria in spot urine from baseline to 2 years and the incidence of cardiovascular and renal outcomes and all-cause mortality during the subsequent 32 months. A greater than or equal to twofold increase in albuminuria from baseline to 2 years, observed in 28{\%}, associated with nearly 50{\%} higher mortality (HR 1.48; 95{\%} CI 1.32 to 1.66), and a greater than or equal to twofold decrease in albuminuria, observed in 21{\%}, associated with 15{\%} lower mortality (HR 0.85; 95{\%} CI 0.74 to 0.98) compared with those with lesser changes in albuminuria, after adjustment for baseline albuminuria, BP, and other potential confounders. Increases in albuminuria also significantly associated with cardiovascular death, composite cardiovascular outcomes (cardiovascular death, myocardial infarction, stroke, and hospitalization for heart failure), and renal outcomes including dialysis or doubling of serum creatinine (adjusted HR 1.40; 95{\%} CI 1.11 to 1.78). In conclusion, in patients with vascular disease, changes in albuminuria predict mortality and cardiovascular and renal outcomes, independent of baseline albuminuria. This suggests that monitoring albuminuria is a useful strategy to help predict cardiovascular risk.",
author = "Schmieder, {Roland E.} and Mann, {Johannes F E} and Helmut Schumacher and Peggy Gao and Giuseppe Mancia and Weber, {Michael A.} and Matthew McQueen and Teo Koon and Salim Yusuf",
year = "2011",
month = "7",
doi = "10.1681/ASN.2010091001",
language = "English",
volume = "22",
pages = "1353--1364",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "7",

}

TY - JOUR

T1 - Changes in albuminuria predict mortality and morbidity in patients with vascular disease

AU - Schmieder, Roland E.

AU - Mann, Johannes F E

AU - Schumacher, Helmut

AU - Gao, Peggy

AU - Mancia, Giuseppe

AU - Weber, Michael A.

AU - McQueen, Matthew

AU - Koon, Teo

AU - Yusuf, Salim

PY - 2011/7

Y1 - 2011/7

N2 - The degree of albuminuria predicts cardiovascular and renal outcomes, but it is not known whether changes in albuminuria also predict similar outcomes. In two multicenter, multinational, prospective observational studies, a central laboratory measured albuminuria in 23,480 patients with vascular disease or high-risk diabetes. We quantified the association between a greater than or equal to twofold change in albuminuria in spot urine from baseline to 2 years and the incidence of cardiovascular and renal outcomes and all-cause mortality during the subsequent 32 months. A greater than or equal to twofold increase in albuminuria from baseline to 2 years, observed in 28%, associated with nearly 50% higher mortality (HR 1.48; 95% CI 1.32 to 1.66), and a greater than or equal to twofold decrease in albuminuria, observed in 21%, associated with 15% lower mortality (HR 0.85; 95% CI 0.74 to 0.98) compared with those with lesser changes in albuminuria, after adjustment for baseline albuminuria, BP, and other potential confounders. Increases in albuminuria also significantly associated with cardiovascular death, composite cardiovascular outcomes (cardiovascular death, myocardial infarction, stroke, and hospitalization for heart failure), and renal outcomes including dialysis or doubling of serum creatinine (adjusted HR 1.40; 95% CI 1.11 to 1.78). In conclusion, in patients with vascular disease, changes in albuminuria predict mortality and cardiovascular and renal outcomes, independent of baseline albuminuria. This suggests that monitoring albuminuria is a useful strategy to help predict cardiovascular risk.

AB - The degree of albuminuria predicts cardiovascular and renal outcomes, but it is not known whether changes in albuminuria also predict similar outcomes. In two multicenter, multinational, prospective observational studies, a central laboratory measured albuminuria in 23,480 patients with vascular disease or high-risk diabetes. We quantified the association between a greater than or equal to twofold change in albuminuria in spot urine from baseline to 2 years and the incidence of cardiovascular and renal outcomes and all-cause mortality during the subsequent 32 months. A greater than or equal to twofold increase in albuminuria from baseline to 2 years, observed in 28%, associated with nearly 50% higher mortality (HR 1.48; 95% CI 1.32 to 1.66), and a greater than or equal to twofold decrease in albuminuria, observed in 21%, associated with 15% lower mortality (HR 0.85; 95% CI 0.74 to 0.98) compared with those with lesser changes in albuminuria, after adjustment for baseline albuminuria, BP, and other potential confounders. Increases in albuminuria also significantly associated with cardiovascular death, composite cardiovascular outcomes (cardiovascular death, myocardial infarction, stroke, and hospitalization for heart failure), and renal outcomes including dialysis or doubling of serum creatinine (adjusted HR 1.40; 95% CI 1.11 to 1.78). In conclusion, in patients with vascular disease, changes in albuminuria predict mortality and cardiovascular and renal outcomes, independent of baseline albuminuria. This suggests that monitoring albuminuria is a useful strategy to help predict cardiovascular risk.

UR - http://www.scopus.com/inward/record.url?scp=79960132102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960132102&partnerID=8YFLogxK

U2 - 10.1681/ASN.2010091001

DO - 10.1681/ASN.2010091001

M3 - Article

VL - 22

SP - 1353

EP - 1364

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 7

ER -